Overview

A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of Diabetes

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
Test the safety, tolerability and improvement of blood sugar control with combination therapy in individuals with Type 2 Diabetes.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Collaborators:
OPKO Health, Inc.
Transition Therapeutics